Life-science applications of the Cambridge Structural Database

Area of Science:

• Structural chemistry
• Medicinal chemistry
• Computational chemistry

Background:

• Small-molecule crystal structures offer insights into in vivo molecular behavior.
• Crystal packing effects are important considerations in molecular modeling.
• The Cambridge Structural Database (CSD) is a key resource for crystallographic data.

Purpose of the Study:

• To highlight the utility of crystallographic data, especially from the CSD, in various aspects of drug design and biological modeling.
• To demonstrate how structural information from crystals complements theoretical calculations.
• To showcase the application of CSD data in developing life-science software.

Main Methods:

• Analysis of torsional distributions from the CSD to map potential-energy surfaces.
• Utilizing CSD data on coordination geometries for metalloenzyme modeling.
• Leveraging CSD information on intermolecular interactions for structure-based inhibitor design.
• Application of crystallographic data in developing computational tools for drug discovery.

Main Results:

• CSD-derived torsional distributions identify experimentally validated conformational minima.
• Crystallographic data provides insights into condensed-phase conformational preferences.
• CSD data assists in modeling ligand binding to metalloenzymes.
• Intermolecular interaction data from CSD guides bioisosteric replacement searches.
• Crystallographic information underpins numerous life-science software applications.

Conclusions:

• Crystallographic data, particularly from the CSD, is a significant tool for the rational design of biologically active molecules.
• The CSD facilitates the development of computational methods for drug discovery and development.
• Integrating crystallographic insights enhances the accuracy and efficiency of molecular modeling in biological contexts.